PRX-03140PRX-03140 is an orally-bioavailable selective partial agonist to the 5-Hydroxytryptamine receptor 4 (5-HT4) and a ligand for the Sigma-1 and Sigma-2 receptors. PRX-03140 is a partial agonist (18% relative to 5-HT ) of the 5-HT4 receptor that was developed by EPIX Pharmaceuticals for Alzheimer's disease. Read from the Drugbox of the Wikipedia article PRX-03140, revision 1346896078.

Property

Value

Formula

C19H27N3O3S, 377.51 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.